COVID-19 is shedding further light on pharmaceutical sourcing strategies and their inherent complexity, explains Jim Morris
NSF's white paper from Jim Morris discusses the importance of streamlining pharma operations in a COVID-19 environment.
He highlights the vital areas that will warrant leadership attention including supplier oversight, inspection readiness and the impact on personnel.
Click here to download the white paper.
